Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.22.2.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Revenues $ 15,450   $ 15,450 $ 141,778
Operating costs and expenses:        
Research and development 725,126 $ 489,503 1,586,479 1,083,176
Selling, general and administrative expenses 887,638 830,967 2,063,465 1,234,935
Total operating expenses 1,612,764 1,320,470 3,649,944 2,318,111
Loss from operations (1,597,314) (1,320,470) (3,634,494) (2,176,333)
Other income (expense):        
Interest income 1 2 1
Interest expense (893,438) (83,280) (1,722,254) (111,924)
Interest expense, related, party (125,706) (244,404) (144,225) (572,346)
Change in fair value of derivative liability   15,282 0 15,282
Change in fair value of warrant liability   438,972 0 438,972
Loss on debt modification   (2,385,204) 0 (2,385,204)
Total income (expense) (1,019,143) (2,258,634) (1,866,477) (2,615,219)
Loss before income taxes (2,616,457) (3,579,104) (5,500,971) (4,791,552)
Provision for income taxes
Net loss (2,616,457) (3,579,104) (5,500,971) (4,791,552)
Common stock warrant and preferred stock deemed dividends (100,000)   (163,172)  
Net loss attributable to common shareholders $ (2,716,457) $ (3,579,104) $ (5,664,143) $ (4,791,552)
Weighted average number of common shares outstanding – basic and diluted (in Shares) 46,357,008 5,300,084 32,722,494 5,300,084
Net loss per common share – basic and diluted (in Dollars per share) $ (0.06) $ (0.68) $ (0.17) $ (0.9)